Press Releases Archives

September 12, 2024

C-Path’s Inaugural Global Impact Conference Charts the Future of Drug Development

C-Path successfully concluded its inaugural Global Impact Conference (CGIC) on September 11, 2024.

September 9, 2024

FDA) encouraged scientists and drug developers to use the alpha-synuclein seed amplification assay (αSyn-SAA) biomarker...

September 5, 2024

Critical Path Institute (C-Path) today announced the addition of significant new data sets...

August 30, 2024

C-Path is honored to announce that FDA Commissioner Robert M. Califf, M.D., MACC, will participate as a panelist...

August 22, 2024

C-Path is thrilled to announce its CPLD Consortium has been awarded a grant from the Ara Parseghian...

August 22, 2024

C-Path proudly announced today a $250,000 grant award to Peter Wipf, Ph.D...

August 20, 2024

C-Path today announced a strategic data sharing partnership with Vivli, the nonprofit...

August 20, 2024

C-Path has received its first data transfer of natural history data on single large-scale mitochondrial DNA...

August 13, 2024

TUCSON, Ariz. August 13, 2024– Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced toda

August 8, 2024

TUCSON, Ariz., August 8, 2024 – Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced tod